HighTower Advisors’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$156K Sell
16,619
-302
-2% -$2.83K ﹤0.01% 3353
2025
Q1
$120K Buy
16,921
+1,282
+8% +$9.12K ﹤0.01% 3303
2024
Q4
$182K Sell
15,639
-4,639
-23% -$54.1K ﹤0.01% 3197
2024
Q3
$415K Sell
20,278
-2,967
-13% -$60.7K ﹤0.01% 2539
2024
Q2
$515K Sell
23,245
-113
-0.5% -$2.5K ﹤0.01% 2288
2024
Q1
$642K Sell
23,358
-439
-2% -$12.1K ﹤0.01% 2093
2023
Q4
$724K Sell
23,797
-1,782
-7% -$54.2K ﹤0.01% 2023
2023
Q3
$808K Sell
25,579
-2,360
-8% -$74.5K ﹤0.01% 1910
2023
Q2
$1.14M Sell
27,939
-427
-2% -$17.4K ﹤0.01% 1679
2023
Q1
$1.06M Buy
28,366
+2,279
+9% +$84.8K ﹤0.01% 1634
2022
Q4
$910K Sell
26,087
-1,708
-6% -$59.6K ﹤0.01% 1726
2022
Q3
$1.56M Buy
27,795
+112
+0.4% +$6.27K ﹤0.01% 1378
2022
Q2
$1.44M Sell
27,683
-5,429
-16% -$282K ﹤0.01% 1435
2022
Q1
$2.41M Sell
33,112
-3,945
-11% -$287K 0.01% 1261
2021
Q4
$4.38M Buy
37,057
+4,873
+15% +$576K 0.01% 972
2021
Q3
$4.32M Buy
32,184
+3,660
+13% +$491K 0.01% 888
2021
Q2
$4.62M Sell
28,524
-6,332
-18% -$1.03M 0.01% 831
2021
Q1
$2.8M Buy
34,856
+5,304
+18% +$425K 0.01% 969
2020
Q4
$1.61M Sell
29,552
-8,552
-22% -$464K 0.01% 999
2020
Q3
$756K Buy
38,104
+23,204
+156% +$460K ﹤0.01% 1358
2020
Q2
$314K Buy
14,900
+1,125
+8% +$23.7K ﹤0.01% 1692
2020
Q1
$168K Sell
13,775
-1,308
-9% -$16K ﹤0.01% 1818
2019
Q4
$219K Sell
15,083
-2,242
-13% -$32.6K ﹤0.01% 1900
2019
Q3
$231K Sell
17,325
-19,112
-52% -$255K ﹤0.01% 1964
2019
Q2
$598K Buy
36,437
+1,826
+5% +$30K ﹤0.01% 1424
2019
Q1
$594K Buy
34,611
+19,885
+135% +$341K ﹤0.01% 1369
2018
Q4
$201K Buy
14,726
+2,115
+17% +$28.9K ﹤0.01% 1837
2018
Q3
$360K Buy
12,611
+4,345
+53% +$124K ﹤0.01% 1631
2018
Q2
$226K Buy
+8,266
New +$226K ﹤0.01% 1837
2018
Q1
Sell
-15,200
Closed -$293K 2127
2017
Q4
$293K Buy
+15,200
New +$293K ﹤0.01% 1714